Last reviewed · How we verify
Autologous dendritic cells pulsed with antigen
Autologous dendritic cells pulsed with antigen is a Small molecule drug developed by Henan Cancer Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Autologous dendritic cells pulsed with antigen |
|---|---|
| Sponsor | Henan Cancer Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma (PHASE1, PHASE2)
- Dendritic Cell Vaccine for Patients With Brain Tumors (PHASE2)
- Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma (PHASE2)
- Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma (PHASE3)
- KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial (EARLY_PHASE1)
- Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients (PHASE1)
- Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells (PHASE1)
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous dendritic cells pulsed with antigen CI brief — competitive landscape report
- Autologous dendritic cells pulsed with antigen updates RSS · CI watch RSS
- Henan Cancer Hospital portfolio CI
Frequently asked questions about Autologous dendritic cells pulsed with antigen
What is Autologous dendritic cells pulsed with antigen?
Autologous dendritic cells pulsed with antigen is a Small molecule drug developed by Henan Cancer Hospital.
Who makes Autologous dendritic cells pulsed with antigen?
Autologous dendritic cells pulsed with antigen is developed by Henan Cancer Hospital (see full Henan Cancer Hospital pipeline at /company/henan-cancer-hospital).
What development phase is Autologous dendritic cells pulsed with antigen in?
Autologous dendritic cells pulsed with antigen is in Phase 1.